Literature DB >> 22399270

Resection of tumors of the neck of the pancreas with venous invasion: the "Whipple at the Splenic Artery (WATSA)" procedure.

Steven M Strasberg1, Luis A Sanchez, William G Hawkins, Ryan C Fields, David C Linehan.   

Abstract

INTRODUCTION: Tumors of the neck of the pancreas may involve the superior mesenteric and portal veins as well as the termination of the splenic vein. This presents a difficult problem since the pancreas cannot be transected through the neck as is standard in a Whipple procedure. Here, we present our method of resecting such tumors, which we term "Whipple at the Splenic Artery (WATSA)".
METHODS: The superior mesenteric and portal veins are isolated below and above the pancreas, respectively. The pancreas and splenic vein are divided just to the right of the point that the splenic artery contacts the superior border of the pancreas. This plane of transection is approximately 2 cm to the left of the pancreatic neck and away from the tumor. The superior mesenteric artery is cleared from the left side of the patient. With the specimen remaining attached only by the superior mesenteric and portal veins, these structures are clamped and divided. Reconstruction is performed with or without a superficial femoral vein graft. The splenic vein is not reconstructed.
RESULTS: Ten cases have been performed to date without mortality. We have previously shown that the pattern of venous collateral development following occlusion of the termination of the splenic vein in the manner described is not similar to that of cases of sinistral (left sided) portal hypertension. DISCUSSION: Whipple at the splenic artery (WATSA) is a safe method for resection of tumors of the neck of the pancreas with vein involvement. It should be performed in high-volume pancreatic surgery centers.

Entities:  

Mesh:

Year:  2012        PMID: 22399270     DOI: 10.1007/s11605-012-1841-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?

Authors:  B Launois; C Stasik; E Bardaxoglou; B Meunier; J P Campion; L Greco; F Sutherland
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

2.  Durability of portal venous reconstruction following resection during pancreaticoduodenectomy.

Authors:  Rory L Smoot; John D Christein; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.

Authors:  Michael B Farnell; Randall K Pearson; Michael G Sarr; Eugene P DiMagno; Lawrence J Burgart; Tamela R Dahl; Nathan Foster; Daniel J Sargent
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

4.  A splenic-inferior mesenteric venous anastomosis prevents gastric congestion following pylorus preserving pancreatoduodenectomy with extensive portal vein resection for cancer of the head of the pancreas.

Authors:  K Tamura; S Sumi; M Koike; S Yano; H Nagami; Y Nio
Journal:  Int Surg       Date:  1997 Apr-Jun

5.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

6.  Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy.

Authors:  J A Stauffer; M K Dougherty; G P Kim; J H Nguyen
Journal:  Br J Surg       Date:  2009-03       Impact factor: 6.939

7.  Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.

Authors:  Robert C G Martin; Charles R Scoggins; Vasili Egnatashvili; Charles A Staley; Kelly M McMasters; David A Kooby
Journal:  Arch Surg       Date:  2009-02

8.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

9.  Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.

Authors:  Yuji Kaneoka; Akihiro Yamaguchi; Masatoshi Isogai
Journal:  Surgery       Date:  2009-02-23       Impact factor: 3.982

10.  Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.

Authors:  Thomas J Howard; Nicholas Villanustre; Seth A Moore; John DeWitt; Julia LeBlanc; Dean Maglinte; Lee McHenry
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  13 in total

1.  Pattern of Venous Collateral Development after Splenic Vein Occlusion in an Extended Whipple Procedure (Whipple at the Splenic Artery) and Long-Term Results.

Authors:  Ismael Dominguez Rosado; Sanjeev Bhalla; Luis A Sanchez; Ryan C Fields; William G Hawkins; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2016-12-05       Impact factor: 3.452

2.  A Novel Classification and Staged Approach for Dissection Along the Celiac and Hepatic Artery During Pancreaticoduodenectomy.

Authors:  Yosuke Inoue; Akio Saiura; Yu Takahashi
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

Review 3.  Management of the splenic vein during a pancreaticoduodenectomy with venous resection for malignancy.

Authors:  Pietro Addeo; Gennaro Nappo; Emanuele Felli; Constantin Oncioiu; François Faitot; Philippe Bachellier
Journal:  Updates Surg       Date:  2016-09-20

Review 4.  Classification and techniques of en bloc venous reconstruction for pancreaticoduodenectomy.

Authors:  Farzad Alemi; Flavio G Rocha; William S Helton; Thomas Biehl; Adnan Alseidi
Journal:  HPB (Oxford)       Date:  2016-07-12       Impact factor: 3.647

5.  Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes.

Authors:  Yonghua Chen; Xing Wang; Nengwen Ke; Gang Mai; Xubao Liu
Journal:  Eur J Med Res       Date:  2014-08-21       Impact factor: 2.175

6.  Significance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection.

Authors:  Kazuyuki Gyoten; Shugo Mizuno; Motonori Nagata; Toru Ogura; Masanobu Usui; Shuji Isaji
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

7.  Venous occlusion test applied to the tributaries of the superior mesenteric veins of the pancreas head infiltrated by tumor.

Authors:  Enio Campos Amico; José Roberto Alves; Samir Assi João; Joafran Alexandre Costa de Medeiros; Rogério Lacerda Sousa
Journal:  J Surg Case Rep       Date:  2017-06-23

8.  Vein resection in patients with adenocarcinoma of the head of pancreas adherent to the portomesenteric venous axis is beneficial despite a high rate of R1 resection.

Authors:  Ramkiran Cherukuru; Sanjay Govil; Mukul Vij; Mohamed Rela
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31

9.  Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.

Authors:  A Oba; H Ito; Y Ono; T Sato; Y Mise; Y Inoue; Y Takahashi; A Saiura
Journal:  BJS Open       Date:  2020-03-19

10.  Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor.

Authors:  Iván A González; Liang-I Kang; Gregory A Williams; Jingxia Liu; David G DeNardo; William G Hawkins; Deyali Chatterjee
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.